Hour24 News
Sophisticated and simple
-
Overview of Befrena’s U.S. Regulatory Milestone Elanco announced that Befrena™ (tirnovetmab), a novel anti-IL31 monoclonal antibody injection, has received approval from the U.S. Department of…
Sophisticated and simple
Overview of Befrena’s U.S. Regulatory Milestone Elanco announced that Befrena™ (tirnovetmab), a novel anti-IL31 monoclonal antibody injection, has received approval from the U.S. Department of…